Tumor suppressor role of phospholipase Cε in Ras-triggered cancers
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Significance: Ras oncogens have been implicated in high proportion of cancers. However, selective treatment for Ras oncogenes is not yet available and components that could mediate Ras functions are being extensively assessed as alternative targets. For some potential targets, such as phospholipase Cε (PLCε), it is not clear how they contribute to tumor development. Here we provide several lines of experimental evidence that support a tumor suppressor function of PLCε, contrasting a positive role of several other well-defined effectors of Ras. Our results show a tumor suppressor role for this PLC in animal models and describe its impact on cell proliferation. Together with observations of marked down-regulation in several types of tumors, this study suggests its use as a biological marker in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · cited 1×
“A mutations in the Ras subfamily of small GTPases contribute to the formation of a large proportion of human tumors (1).”
BackgroundSmall molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
Zimmermann, G., Papke, B., Ismail, S., Vartak, N., Chandra, A., Hoffmann, M., Hahn, S. A., Triola, G., Wittinghofer, A., Bastiaens, P. I. H., et al. (2013) · Nature · doi:10.1038/nature12205 · Cited by 596
Puyol, M., Martín, A., Dubus, P., Mulero, F., Pizcueta, P., Khan, G., Guerra, C., Santamaría, D., & Barbacid, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.025 · Cited by 415
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
Bunney, T. D., & Katan, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2842 · Cited by 400 · cited 1×
“In assessing functions related to cancer, however, only the Plce1 transgene—where the link between PLCe and a phenotype could be more difficult to interpret—has been used so far (16, 17).”
BackgroundSelf-citationBlasco, R. B., Francoz, S., Santamaría, D., Cañamero, M., Dubus, P., Charron, J., Baccarini, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.002 · Cited by 302 · cited 3×
“These results indicate that in the NSCLC model, where initiation of KrasG12D expression is synchronized and a rapid down-regulation of PLCe is seen in KrasG12D-expressing MEFs, the Plce−/− genotype does not have an effect on tumor burden in the lung.”
BackgroundPLC regulation: emerging pictures for molecular mechanisms
Bunney, T. D., & Katan, M. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.003 · Cited by 182
Self-citationPeschard, P., McCarthy, A., Leblanc-Dominguez, V., Yeo, M., Guichard, S., Stamp, G., & Marshall, C. J. (2012) · Current Biology · doi:10.1016/j.cub.2012.09.013 · Cited by 82
Self-citation
Cited by
Ras Conformational Ensembles, Allostery, and Signaling
Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00542 · Cited by 355
Dysfunction of phospholipase Cγ in immune disorders and cancer
Koss, H., Bunney, T. D., Behjati, S., & Katan, M. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.09.004 · Cited by 115
Self-citationPhospholipase C families: Common themes and versatility in physiology and pathology
Katan, M., & Cockcroft, S. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101065 · Cited by 89
Self-citationThe effects of mutant Ras proteins on the cell signalome
Takács, T., Kudlik, G., Kurilla, A., Szeder, B., Buday, L., & Vas, V. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09912-8 · Cited by 62
Lo Vasco, V. R., Leopizzi, M., Puggioni, C., & Della Rocca, C. (2014) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-014-0235-9 · Cited by 15
Metadata
- Authors
- Martins, M., McCarthy, A., Baxendale, R., Guichard, S., Magno, L., Kessaris, N., El-Bahrawy, M., Yu, P., & Katan, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-03-03
- Volume
- 111
- Issue
- 11
- Pages
- 4239-4244
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2093126286
- Cited by
- 51
- References
- 7
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor suppressor role of phospholipase Cε in Ras-triggered cancers. https://app.cochat.ai/papers/10.1073/pnas.1311500111
- The paper
- Martins, M., McCarthy, A., Baxendale, R., Guichard, S., Magno, L., Kessaris, N., El-Bahrawy, M., Yu, P., & Katan, M. (2014). Tumor suppressor role of phospholipase Cε in Ras-triggered cancers. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1311500111
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.